• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

左心室射血分数保留的肥厚型心肌病患者的左心室应变模式及其与心脏生物标志物的关系。

Left ventricular strain patterns and their relationships with cardiac biomarkers in hypertrophic cardiomyopathy patients with preserved left ventricular ejection fraction.

作者信息

Zhang Lisha, Wan Yixuan, He Bo, Wang Lei, Zhu Dongyong, Gao Fabao

机构信息

Department of Radiology, West China Hospital, Sichuan University, Chengdu, China.

Molecular Imaging Center, West China Hospital, Sichuan University, Chengdu, China.

出版信息

Front Cardiovasc Med. 2022 Oct 4;9:963110. doi: 10.3389/fcvm.2022.963110. eCollection 2022.

DOI:10.3389/fcvm.2022.963110
PMID:36267632
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9577012/
Abstract

AIMS

This study aims to assess left ventricular (LV) function in hypertrophic cardiomyopathy (HCM) patients with preserved left ventricular ejection fraction (LVEF) by LV strain patterns based on cardiac magnetic resonance feature tracking (CMR-FT) and to explore the relationships between LV strain patterns and cardiac biomarkers in these patients, such as cardiac troponin (cTnT) and N-terminal prohormone of the brain natriuretic peptide (NT-proBNP).

METHODS

A total of 64 HCM patients with preserved LVEF and 33 healthy people were included in this study. All subjects underwent contrast-enhanced CMR, and all patients took blood tests for cTnT and NT-proBNP during hospitalization.

RESULTS

Despite the absence of a significant difference in LVEF between HCM patients and healthy controls, almost all global and segmental strains in radial, circumferential, and longitudinal directions in the HCM group deteriorated significantly as compared to controls ( < 0.05). Moreover, some global and segmental strains correlated significantly with NT-proBNP and cTnT in HCM patients, and the best correlations were global radial strain (GRS) (r = -0.553, < 0.001) and mid-ventricular radial strain (MRS) (r = -0.582, < 0.001), respectively, with a moderate correlation. The receiver operating characteristic (ROC) results showed that among the LV deformation parameters, GRS [area under the curve (AUC), 0.76; sensitivity, 0.49; specificity, 1.00], MRS (AUC, 0.81; sensitivity, 0.77; specificity, 0.79) demonstrated greater diagnostic accuracy to predict elevated NT-proBNP, and abnormal cTnT, respectively. Their cut-off values were 21.17 and 20.94%, respectively. Finally, all global strains demonstrated moderate, good, and excellent intra- and inter-observer reproducibility.

CONCLUSION

LV strain patterns can be used to assess the subclinical cardiac function of HCM patients on the merit of being more sensitive than LVEF. In addition, LV strain patterns can detect serious HCM patients and may be helpful to non-invasively predict elevated NT-proBNP and cTnT.

摘要

目的

本研究旨在通过基于心脏磁共振特征追踪(CMR-FT)的左室应变模式评估左室射血分数(LVEF)保留的肥厚型心肌病(HCM)患者的左室(LV)功能,并探讨这些患者左室应变模式与心脏生物标志物之间的关系,如心肌肌钙蛋白(cTnT)和脑钠肽前体N末端(NT-proBNP)。

方法

本研究共纳入64例LVEF保留的HCM患者和33名健康人。所有受试者均接受对比增强CMR检查,所有患者在住院期间均进行了cTnT和NT-proBNP的血液检测。

结果

尽管HCM患者与健康对照者的LVEF无显著差异,但与对照组相比,HCM组几乎所有径向、圆周和纵向方向的整体及节段应变均显著恶化(<0.05)。此外,HCM患者的一些整体及节段应变与NT-proBNP和cTnT显著相关,最佳相关性分别为整体径向应变(GRS)(r = -0.553,<0.001)和心室中部径向应变(MRS)(r = -0.582,<0.001),呈中度相关。受试者工作特征(ROC)结果显示,在左室变形参数中,GRS[曲线下面积(AUC),0.76;敏感性,0.49;特异性,1.00]、MRS(AUC,0.81;敏感性,0.77;特异性,0.79)分别对预测NT-proBNP升高和cTnT异常具有更高的诊断准确性。它们的截断值分别为21.17%和20.94%。最后,所有整体应变在观察者内和观察者间均表现出中度、良好和优秀的可重复性。

结论

左室应变模式可用于评估HCM患者的亚临床心脏功能,因其比LVEF更敏感。此外,左室应变模式可检测出严重的HCM患者,可能有助于无创预测NT-proBNP和cTnT升高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f2d/9577012/8864c6aa4bfc/fcvm-09-963110-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f2d/9577012/8864c6aa4bfc/fcvm-09-963110-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f2d/9577012/8864c6aa4bfc/fcvm-09-963110-g0002.jpg

相似文献

1
Left ventricular strain patterns and their relationships with cardiac biomarkers in hypertrophic cardiomyopathy patients with preserved left ventricular ejection fraction.左心室射血分数保留的肥厚型心肌病患者的左心室应变模式及其与心脏生物标志物的关系。
Front Cardiovasc Med. 2022 Oct 4;9:963110. doi: 10.3389/fcvm.2022.963110. eCollection 2022.
2
CMR feature tracking strain patterns and their association with circulating cardiac biomarkers in patients with hypertrophic cardiomyopathy.肥厚型心肌病患者的心脏磁共振特征追踪应变模式及其与循环心脏生物标志物的关联
Clin Res Cardiol. 2021 Nov;110(11):1757-1769. doi: 10.1007/s00392-021-01848-5. Epub 2021 Mar 29.
3
Advanced myocardial characterization in hypertrophic cardiomyopathy: feasibility of CMR-based feature tracking strain analysis in a case-control study.肥厚型心肌病的心肌高级特征分析:基于 CMR 的特征追踪应变分析在病例对照研究中的可行性。
Eur Radiol. 2020 Nov;30(11):6118-6128. doi: 10.1007/s00330-020-06922-6. Epub 2020 Jun 25.
4
The Combination of Feature Tracking and Late Gadolinium Enhancement for Identification Between Hypertrophic Cardiomyopathy and Hypertensive Heart Disease.特征跟踪与延迟钆增强相结合用于肥厚型心肌病与高血压性心脏病的鉴别诊断
Front Cardiovasc Med. 2022 May 11;9:865615. doi: 10.3389/fcvm.2022.865615. eCollection 2022.
5
CMR left ventricular strains beyond global longitudinal strain in differentiating light-chain cardiac amyloidosis from hypertrophic cardiomyopathy.心脏磁共振成像左心室应变(除整体纵向应变外)在区分轻链型心脏淀粉样变性与肥厚型心肌病中的作用
Front Cardiovasc Med. 2023 May 3;10:1108408. doi: 10.3389/fcvm.2023.1108408. eCollection 2023.
6
Cardiac Magnetic Resonance Feature-Tracking Identifies Preclinical Abnormalities in Hypertrophic Cardiomyopathy Sarcomere Gene Mutation Carriers.心脏磁共振特征追踪技术可识别肥厚型心肌病肌节基因突变携带者的临床前异常。
Circ Cardiovasc Imaging. 2024 Apr;17(4):e016042. doi: 10.1161/CIRCIMAGING.123.016042. Epub 2024 Apr 2.
7
Left atrial and left ventricular strain in feature-tracking cardiac magnetic resonance for predicting patients at high risk of sudden cardiac death in hypertrophic cardiomyopathy.特征追踪心脏磁共振成像中左心房和左心室应变用于预测肥厚型心肌病心脏性猝死高危患者
Quant Imaging Med Surg. 2024 May 1;14(5):3544-3556. doi: 10.21037/qims-23-1615. Epub 2024 Apr 22.
8
Predictive values of multiple non-invasive markers for myocardial fibrosis in hypertrophic cardiomyopathy patients with preserved ejection fraction.多种无创标志物对射血分数保留型肥厚型心肌病患者心肌纤维化的预测价值。
Sci Rep. 2021 Feb 22;11(1):4297. doi: 10.1038/s41598-021-83678-z.
9
Degree and distribution of left ventricular hypertrophy as a determining factor for elevated natriuretic peptide levels in patients with hypertrophic cardiomyopathy: insights from cardiac magnetic resonance imaging.左心室肥厚程度和分布作为肥厚型心肌病患者升高的利钠肽水平的决定因素:心脏磁共振成像的见解。
Int J Cardiovasc Imaging. 2012 Apr;28(4):763-72. doi: 10.1007/s10554-011-9876-4. Epub 2011 Apr 24.
10
Amount of left ventricular hypertrophy determines the plasma N-terminal pro-brain natriuretic peptide level in patients with hypertrophic cardiomyopathy and normal left ventricular ejection fraction.肥厚型心肌病且左心室射血分数正常患者的左心室肥厚程度决定血浆N末端脑钠肽前体水平。
Clin Cardiol. 2006 Apr;29(4):155-60. doi: 10.1002/clc.4960290406.

引用本文的文献

1
Cardiac Magnetic Resonance in Heart Failure: Diagnostic and Prognostic Assessments.心力衰竭中的心脏磁共振成像:诊断与预后评估
J Cardiovasc Dev Dis. 2025 May 23;12(6):200. doi: 10.3390/jcdd12060200.
2
Differences Between Two Distinct Hypertrophic Cardiac Conditions: Fabry Disease versus Hypertrophic Cardiomyopathy.两种不同肥厚型心肌病变的差异:法布瑞氏症与肥厚型心肌病变。
Arq Bras Cardiol. 2024 Jan;121(1):e20230229. doi: 10.36660/abc.20230229.

本文引用的文献

1
Right ventricular function declines prior to left ventricular ejection fraction in hypertrophic cardiomyopathy.肥厚型心肌病患者的右心室功能在左心室射血分数之前下降。
J Cardiovasc Magn Reson. 2022 Jun 13;24(1):36. doi: 10.1186/s12968-022-00868-y.
2
Identification of heart failure with preserved ejection fraction helps risk stratification for hypertrophic cardiomyopathy.射血分数保留的心力衰竭的识别有助于肥厚型心肌病的危险分层。
BMC Med. 2022 Jan 26;20(1):21. doi: 10.1186/s12916-021-02219-7.
3
Titin-Related Dilated Cardiomyopathy: The Clinical Trajectory and the Role of Circulating Biomarkers in the Clinical Assessment.
与肌联蛋白相关的扩张型心肌病:临床病程及循环生物标志物在临床评估中的作用
Diagnostics (Basel). 2021 Dec 22;12(1):13. doi: 10.3390/diagnostics12010013.
4
Myocardial mechanics in dilated cardiomyopathy: prognostic value of left ventricular torsion and strain.扩张型心肌病的心肌力学:左心室扭转和应变的预后价值。
J Cardiovasc Magn Reson. 2021 Dec 2;23(1):136. doi: 10.1186/s12968-021-00829-x.
5
Prognostic role of global longitudinal strain by feature tracking in patients with hypertrophic cardiomyopathy: The STRAIN-HCM study.特征追踪技术检测肥厚型心肌病患者整体纵向应变的预后价值:STRAIN-HCM 研究。
Int J Cardiol. 2021 Dec 15;345:61-67. doi: 10.1016/j.ijcard.2021.10.148. Epub 2021 Oct 30.
6
Left Ventricular Longitudinal Dyssynchrony by CMR Feature Tracking Is Related to Adverse Prognosis in Advanced Arrhythmogenic Cardiomyopathy.通过心脏磁共振特征追踪检测的左心室纵向不同步与晚期致心律失常性心肌病的不良预后相关。
Front Cardiovasc Med. 2021 Oct 11;8:712832. doi: 10.3389/fcvm.2021.712832. eCollection 2021.
7
Predictive values of multiple non-invasive markers for myocardial fibrosis in hypertrophic cardiomyopathy patients with preserved ejection fraction.多种无创标志物对射血分数保留型肥厚型心肌病患者心肌纤维化的预测价值。
Sci Rep. 2021 Feb 22;11(1):4297. doi: 10.1038/s41598-021-83678-z.
8
N-terminal pro-brain natriuretic peptide and sudden cardiac death in hypertrophic cardiomyopathy.脑钠肽前体 N 端与肥厚型心肌病的心脏性猝死。
Heart. 2021 Oct;107(19):1576-1583. doi: 10.1136/heartjnl-2020-317701. Epub 2020 Dec 24.
9
Elevation of high-sensitivity cardiac troponin T and left ventricular remodelling in hypertrophic cardiomyopathy.肥厚型心肌病中高敏心肌肌钙蛋白T升高与左心室重构
ESC Heart Fail. 2020 Dec;7(6):3593-3600. doi: 10.1002/ehf2.12852. Epub 2020 Oct 12.
10
NT-proBNP by Itself Predicts Death and Cardiovascular Events in High-Risk Patients With Type 2 Diabetes Mellitus.NT-proBNP 单独预测 2 型糖尿病高危患者的死亡和心血管事件。
J Am Heart Assoc. 2020 Oct 20;9(19):e017462. doi: 10.1161/JAHA.120.017462. Epub 2020 Sep 23.